Expertise

Molecular Pathology with focus on mutational analysis in cancers and Human papillomavirus derived cancers; Expertise on clinical diagnostic technologies for cervical screening purposes; Clinical technologies for detection of HPV in non-gynaecology cancers; Detection and characterization of treatment defining mutations in tumors; Biobanks; Guidelines; Private-public collaborations  

Primære forskningsområder

Human papilomavirus in cancers; Colo-rectal cancer characterization with respect to tumor mutations; Epigenetic changes in cancers 

Aktuel forskning

Human papilomavirus in cancers; Colo-rectal cancer characterization with respect to tumor mutations; Epigenetic changes in cancers 

Mulige interessekonflikter

Jesper Bonde has within the last five years served as a paid advisor to Roche Molecular Systems, and Genomica SAU, and has received honoraria or travel costs compensation from Hologic, Roche, QIAGEN, Genomica, and BD Diagnostics, European Cytology Association, International Cytology Association, International Papillomavirus Society, and American Society of Clinical Virology for lectures. He is principal investigator on studies funded by BD Diagnostics.